首页 › 肝癌（肝细胞癌） › 俄亥俄州 › Cleveland
Cleveland OH 肝癌（肝细胞癌）临床试验
18项针对 肝癌（肝细胞癌）的研究正在 Cleveland及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
The Vanguard Study: Testing a New Way to Screen for Cancer
招募中欢迎健康志愿者
- Louis Stokes Cleveland VA Medical Center, Cleveland
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
招募中1 期
- Exelixis Clinical Site #10, Cleveland
Symbiotic-GI-13: A Study to Learn About Study Medicine Called PF-08634404 as a Single Treatment and Combination Treatment in Adult Participants With a Liver Cancer Called Hepatocellular Carcinoma, That is Too Advanced to be Removed by Surgery and May Have Spread to Other Parts of the Body.
招募中1/2 期
- University Hospitals Cleveland Medical Center, Cleveland
National Liver Cancer Screening Trial
招募中4 期
- The Cleveland Clinic, Cleveland
A Study Evaluating a New Radiation Treatment Workflow (NGDS)
招募中
- University Hospital Cleveland Medical Center, Cleveland
Real-world Evaluation of the HistoSonics Edison System for Treatment of Liver Tumors Across Multidisciplinary Users (BOOMBOX: Master Study)
招募中观察性研究
- Cleveland Clinic Foundation, Cleveland
FOG-001 in Locally Advanced or Metastatic Solid Tumors
招募中1/2 期
- University Hospitals Cleveland Medical Center, Seidman Cancer Center, Cleveland
- Cleveland Clinic, Cleveland
Testing Immunotherapy With or Without Stereotactic Body Radiation Therapy in Patients With Advanced Liver Cancer, HELIO-RT Trial
招募中3 期
- Case Western Reserve University, Cleveland
- UHHS-Chagrin Highlands Medical Center, Beachwood · 距离 10 英里
- UH Seidman Cancer Center at Lake Health Mentor Campus, Mentor · 距离 22 英里
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
招募中1 期
- University Hospitals Cleveland Medical Center, Cleveland
DRAGON Registry - International Multicenter Registry and Medical Image Bank for Patients With Primarily Unresectable Liver Cancer or Liver Metastases That Underwent Combined Portal and Hepatic Vein Embolization (PVE/HVE) to Increase Future Liver Remnant Before Resection.
招募中观察性研究
- Cleveland Clinic, Cleveland
A Study to Evaluate ALN-BCAT in Patients With Hepatocellular Carcinoma
招募中1 期
- Clinical Trial Site, Cleveland
Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI
招募中
- Louis Stokes VA Medical Center, Cleveland, OH, Cleveland
68Ga-PSMA-11 PET-directed Radioligand Therapy in Metastatic Hepatocellular Carcinoma (HCC)
招募中2 期
- Case Comprehensive Cancer Center, University Hospitals Cleveland Medical Center, Seidman Cancer Center, Cleveland
A Study of TTI-101 as Monotherapy and in Combination in Participants With Locally Advanced or Metastatic, and Unresectable Hepatocellular Carcinoma
招募中1/2 期
- Cleveland Clinic Lerner College of Medicine, Cleveland
HOPE Against Cancer Recurrence in HCC
招募中4 期
- Cleveland Clinic, Cleveland
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
招募中观察性研究
- Massive Bio SYNERGY-AI site, Mayfield Heights · 距离 12 英里
The Dragon PLC Trial (DRAGON-PLC)
招募中
- Cleveland Clinic, Cleveland
A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)
招募中1/2 期
- Cleveland Clinic, Cleveland
其他城市的 肝癌（肝细胞癌）试验
- Houston, TX31 项研究
- New York City, NY24 项研究
- Dallas, TX19 项研究
- Los Angeles, CA19 项研究
- Boston, MA18 项研究
- Chicago, IL16 项研究
- Philadelphia, PA16 项研究
- Pittsburgh, PA15 项研究
- San Francisco, CA14 项研究
- Orange, CA14 项研究
- Jacksonville, FL14 项研究
- San Antonio, TX13 项研究
Cleveland的其他研究
- 非小细胞肺癌43 项研究
- 癌症（所有类型）36 项研究
- 乳腺癌35 项研究
- 前列腺癌34 项研究
- 心力衰竭33 项研究
- 卵巢癌30 项研究
- 转移性癌症30 项研究
- 肺癌26 项研究
- 结直肠癌24 项研究
- 心血管疾病22 项研究
- 子宫内膜癌20 项研究
- 急性髓系白血病20 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月6日。每项研究自行设定入选标准，由研究团队决定谁能参与。